Bobo-Newton acute myocarditis caused by Capnocytophaga canimorsus: a case report.

Background: Capnocytophaga canimorsus is a Gram-negative bacillus commensal of the oral cavities of dogs and cats that can cause human infection after a bite or scratch. Cardiovascular manifestations have included endocarditis, heart failure, acute myocardial infarction, mycotic aortic aneurysm and prosthetic aortitis. Case summary: A 37-year-old male presented septic manifestations, ST-segment alterations on the electrocardiogram and troponin rise, 3 days after a dog bite. N-terminal brain natriuretic peptide was elevated and transthoracic echocardiography revealed mild diffuse left ventricular (LV) hypokinesia. Coronary computed tomography angiography showed normal coronary arteries. Two aerobic blood cultures grew Capnocytophaga canimorsus. On Day 5, cardiovascular magnetic resonance (CMR), showed all diagnostic criteria of acute myocarditis, including focal areas of subepicardial oedema in the LV inferolateral wall, early hyperenhancement, nodular or linear foci of late gadolinium enhancement, increased T2-times and extracellular volume fraction. The outcome was favourable with amoxicillin. Discussion: Four cases of myocardial infarction caused by Capnocytophaga canimorsus had been reported and coronary angiography showed normal coronary arteries in 3 cases. Herein, we report a case of documented acute myocarditis associated with Capnocytophaga canimorsus infection. Myocarditis was demonstrated by comprehensive CMR revealing all established diagnostic criteria. Acute myocarditis should be ruled out in patients with Capnocytophaga canimorsus infection and a clinical presentation of "acute myocardial infarction", especially in those with unobstructed coronary arteries.

Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis.

PURPOSE: Previous studies support the potential efficacy of venovenous extracorporeal membrane oxygenation (vvECMO) for improving survival in severe acute respiratory distress syndrome (ARDS) cases. Prone positioning (PP) has been shown to improve the outcomes of moderate-to-severe ARDS patients. Few studies and no randomized controlled trials have evaluated the effect of PP performed in ECMO patients. METHODS: We performed a systematic review and meta-analysis examining the effect of prone positioning for ARDS patients receiving vvECMO on survival. All authors were contacted to obtain complementary information not mentioned in the original articles. The main objective was to compare 28-day survival in vvECMO patients with PP to vvECMO patients without PP (controls). RESULTS: Thirteen studies with a combined population of 1836 patients satisfied the inclusion criteria. PP was associated with a significant improvement in 28-day survival (503 survivors among 681 patients in the PP group [74%; 95% CI 71-77] vs. 450 survivors among 770 patients in the control group [58%, 95% CI 55-62]; RR 1.31 [95% CI 1.21-1.41]; I2 22% [95% CI 0-62%]; P < 0.0001). Survival was also improved in terms of other endpoints (60-day survival, 90-day survival, ICU survival, and hospital survival). In contrast, the duration of mechanical ventilation was increased in vvECMO patients with PP (mean difference 11.4 days [95% CI 9.2-13.5]; 0.64 [95% CI 0.50-0.78]; I2 8%; P < 0.0001). CONCLUSION: According to this meta-analysis, survival was improved when prone positioning was used in ARDS patients receiving vvECMO. The impact of this combination on survival should be investigated in prospective randomized controlled trials.

[A case of bone marrow necrosis and fat embolism in a sickle-cell disease patient]. / Un cas de nécrose médullaire compliquée d'embolie graisseuse chez un patient drépanocytaire.

We report here a case of bone marrow necrosis and fat embolism syndrome in a 23-year-old sickle-cell disease (HbSS) patient. A brutal and severe bicytopenia conducted to suspect bone marrow necrosis, confirmed by bone marrow aspiration and analysis. This was the first life-threatening medical event for this patient. In the present case, a complex alloimmunization against blood group antigens complicated the treatment because of the risks associated with the transfusion strategy. These rare complications of sickle-cell disease may be fatal, but an efficient symptomatic treatment generally allows for recovery. Medical biologists should be aware of the danger of bone marrow necrosis in sickle-cell disease, so that they can help clinicians and accurately diagnose this serious complication.